Statistics
Publications
4
Citations
294
H-Index
4
Active since
2008
Affiliations
MerLion Pharma (Germany)(Current)
Klaus Fink is an author at MerLion Pharma (Germany) specializing in botulinum toxin therapy, botulinum toxins, and botulinum neurotoxin.
Publications per year
2008–2011
4
4
Studies on the dissociation of botulinum neurotoxin type A complexes
Karl‐Heinz Eisele, Klaus Fink, Martin Vey et al. · Toxicon · 2010 · 172 citations
Equivalent potency of Xeomin® and BOTOX®
Dirk Dressler, Gerd J. Mander, Klaus Fink · Toxicon · 2008 · 19 citations
1–4 of 4